All filters
Slidesets
Use of Integrase Inhibitors in special populations | Omar Sued, MSc, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Clinical use of Integrase Inhibitors | Eugenia Negredo, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Use of Integrase Inhibitors in Latin America | Mônica Jacques de Moraes, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Clinical case presentation | Eugenia Negredo, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Dual therapy regimens | Maria Ines Figueroa, MD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
HIV Integrase Inhibitors: A new mechanism of action | Charles Boucher, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Pharmacology and new modes of delivery | David Back, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Meeting
European HIV Clinical Forum 2018
Slidesets
Longer duration of virological suppression and a fully active companion drug ensure a high rate of virological control in HIV-1 infected patients switching to a dual therapy containing integrase inhibitors- Daniele Armenia
Presented at:
European HIV Clinical Forum 2018
Slidesets
Integrase inhibitors in specific populations- Women and those aging with HIV- Sharon Walmsley, FRCPC, MD, MSC
Presented at:
European HIV Clinical Forum 2018
Slidesets
Long-acting ARV for treatment & prevention: clinical considerations- Laura Waters, MD, FRCP
Presented at:
European HIV Clinical Forum 2018
Slidesets
Pharmacologic characteristics and delivery options for integrase inhibitors- Courtney Fletcher, PharmD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Intergrase inhibitors- What's new?-Margaret Johnson, MD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Resistance to integrase inhibitors- What clinicians need to know- Roger Paredes, MD, PhD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Reduced drug regimens- What are the data?- Jose Arribas, MD
Presented at:
European HIV Clinical Forum 2018
Slidesets
Switching antiretroviral therapy to safer strategies based on intergrase inhibitors- Pedro Cahn, MD, PhD
Presented at:
European HIV Clinical Forum 2018
Slidesets
What do we know already?- Sinead Delaney, MBBCh, MSc, DTM&H, PhD
Presented at:
International Workshop on HIV & Adolescence 2018
Slidesets
Ethical-legal considerations for clinical trials for adolescents- Marc Blockman, MBChB, MMed
Presented at:
International Workshop on HIV & Adolescence 2018
Slidesets
Social and behavioral considerations for adolescents- Millicent Atujuna
Presented at:
International Workshop on HIV & Adolescence 2018
Slidesets
Considerations for vulnerable and marginalized adolescents- Webster Mavhu, PhD
Presented at:
International Workshop on HIV & Adolescence 2018
Slidesets
Service delivery trials- Jenala Chipungu
Presented at:
International Workshop on HIV & Adolescence 2018
Slidesets
What are the trial design issues for adolescents?- Lee Fairlie, MBChB, FCPaeds
Presented at:
International Workshop on HIV & Adolescence 2018
Slidesets
MoH experience- Hilda Bara, MPH, MBChB
Presented at:
International Workshop on HIV & Adolescence 2018